Silver Point Capital Sells Stake in Cooper-Standard Holdings Inc. (CPS)

Silver Point Capital, managed by Edward A. Mule, has reduced its stake in Cooper-Standard Holdings Inc. (NYSE:CPS), a new filing with the U.S. Securities and Exchange Commission showed. The fund has sold 4700 shares of the company’s common stock in two transactions for an average price of around $67.88 for an aggregate price of about $319,038.Following the sale, Silver Point still owns 4.76 million shares, up from 4.72 million shares the fund disclosed in its latest 13F filing.

CooperStandard

Michigan-based Cooper-Standard Holdings Inc. (NYSE:CPS) is a global supplier of systems and components for the automotive industry. The company increased its first-quarter 2014 revenue by 12% to $837.6 million, compared to $747.6 million for the first quarter of 2013. It posted net income of $19.7 million, or $1.10 per share on a fully diluted basis, in the first quarter, compared to $20.7 million, or $0.86 per share, in the same period in 2013.

On Monday, Cooper-Standard Holdings Inc. (NYSE: CPS) said that it agreed to sell its thermal and emissions product line to Halla Visteon Climate Control Corp. The company believes that the sale will it to focus on the product lines where it holds a leading market position and can gain the greatest competitive advantage.

Cooper-Standard Holdings Inc. (NYSE:CPS) has a market cap of $1.12 billion. Shares of the company on Tuesday traded down by 0.65%, hitting $65.73. It has a 52 week high of $71.11 and a 52 week low of $45.50.

Connecticut-based Silver Point Capital is a distressed debt and credit-focused private investment firm. It was founded in 2002 by Edward A. Mule and Robert J. O’Shea. The value of the fund’s equity portfolio was $1.15 billion as of the end of the first quarter of 2014. The fund disclosed its largest stake, in term of value, in American International Group Inc. (NYSE:AIG), holding 7.20 million shares, with a reported value of $360.12 million as of the end of March 2014.

Disclosure: none

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!